LipidArt

Ownership

Private

Employees

~2

Therapeutic Areas

OncologyNeurologyMetabolic Disorders

Stage

Preclinical

Preclinical

Phase 1

Phase 2

Phase 3

Approved

Modalities

Small moleculessynthetic compounds

LipidArt General Information

The company has discovered a family of new compounds which are able to modify Hsp function

Contact Information

Website

http://www.lipidart.com/

Primary Industry

Biotech

Corporate Office

Szeged, Csongrad
Hungary

Drug Pipeline

No pipeline data available

For full access to LipidArt's pipeline data

Key Partnerships

Biological Research Centre of the Hungarian Academy of Sciences (BRC)

Need more data on over 80,000 life science companies, including over 1200 biotechs?

LipidArt Funding

No funding data available

Early Stage VC (Series A)	04-Jun-2020	$38M	Completed	Phase 1
Seed Round	12-Feb-2019	$8.5M	Completed	Startup

Interested in comprehensive profile data?

We'll help you find what you need

To view LipidArt's complete valuation and funding history, request access »

LipidArt Financial Metrics